Abstract:Background and purpose This study was to investigate the association of H-type hypertension with the odds of incident stroke and stroke death in Chinese adults. Methods 39,165 Chinese adults aged 35 years or older who had no history of stroke at baseline were prospectively followed to determine major cardiovascular events, with an average follow-up of 6.2 years. Using a nested case–control design, this report included 179 incident stroke cases (121 stroke deaths) and 179 controls without vascular events matched by age, sex, community, and length of plasma storage from the cohort. Baseline plasma total homocysteine (tHcy) level was measured for all the included subjects. Hypertensive patients, co-morbid with elevated plasma homocysteine levels, are defined as H-type hypertension. Logistic regression analysis was performed to investigate the associations of H-type hypertension with the odds of incident stroke and stroke death, with adjustment for important covariates. Results When analyzed individually, compared to subjects with tHcy<10 μmol/L, the OR (95% CI) of incident stroke for those with tHcy≥10 μmol/L but <20 μmol/L and tHcy≥20 μmol/L were 1.7 (0.8–3.7) and 2.9 (1.1–8.0), respectively. Hypertension was also independently associated with higher risk of incident stroke: 4.7 (2.8–7.9), compared to those without hypertension. When analyzed together, the highest risk was found among subjects with both hyperhomocysteinemia and hypertension (H-type hypertension): 13.5 (3.0–61.5) for incident stroke and 12.4 (2.7 to 58.1) for stroke death. Conclusion This study provided strong evidence that hyperhomocysteinemia and hypertension were two independent, modifiable risk factors, which acted at least additively to increase the risk of incident stroke and stroke death in Chinese population. Background and purpose This study was to investigate the association of H-type hypertension with the odds of incident stroke and stroke death in Chinese adults. Methods 39,165 Chinese adults aged 35 years or older who had no history of stroke at baseline were prospectively followed to determine major cardiovascular events, with an average follow-up of 6.2 years. Using a nested case–control design, this report included 179 incident stroke cases (121 stroke deaths) and 179 controls without vascular events matched by age, sex, community, and length of plasma storage from the cohort. Baseline plasma total homocysteine (tHcy) level was measured for all the included subjects. Hypertensive patients, co-morbid with elevated plasma homocysteine levels, are defined as H-type hypertension. Logistic regression analysis was performed to investigate the associations of H-type hypertension with the odds of incident stroke and stroke death, with adjustment for important covariates. Results When analyzed individually, compared to subjects with tHcy<10 μmol/L, the OR (95% CI) of incident stroke for those with tHcy≥10 μmol/L but <20 μmol/L and tHcy≥20 μmol/L were 1.7 (0.8–3.7) and 2.9 (1.1–8.0), respectively. Hypertension was also independently associated with higher risk of incident stroke: 4.7 (2.8–7.9), compared to those without hypertension. When analyzed together, the highest risk was found among subjects with both hyperhomocysteinemia and hypertension (H-type hypertension): 13.5 (3.0–61.5) for incident stroke and 12.4 (2.7 to 58.1) for stroke death. Conclusion This study provided strong evidence that hyperhomocysteinemia and hypertension were two independent, modifiable risk factors, which acted at least additively to increase the risk of incident stroke and stroke death in Chinese population.

Hypertension with Elevated Homocysteine——H Type Hypertension

Lowering blood pressure and plasma homocysteine:a dual treatment approach for H-type hypertension

Homocysteine, hyperhomocysteinemia, and H-type hypertension

Clinical Significance of Plasma Homocysteine in the Coronary Atherosclerosis Patients

Mechanism and Prevention of H -type Hypertension

H-type Hypertension and Risk of Stroke in Chinese Adults: A Prospective, Nested Case–control Study

Homocysteine, Ischemic Stroke, and Coronary Heart Disease in Hypertensive Patients

Association of High Homocysteine Levels With the Risk Stratification in Hypertensive Patients at Risk of Stroke

H-type Hypertension and Risk of Stroke: A Prospective, Nested Case–control Study

Prevalence and clinical correlates of hyperhomocysteinemia in Chinese urban population with hypertension

Homocysteine and Stroke Risk

The Association Between Total Homocysteine and Blood Pressure in Two Independent Chinese Populations.

Elevated Serum Homocysteine,mthfr Gene Mutation and Essential Hypertension in Chinese

Folic Acid and Vitamins D and B12 Correlate with Homocysteine in Chinese Patients with Type-2 Diabetes Mellitus, Hypertension, or Cardiovascular Disease

Homocysteine,blood lipid,renal function and carotid ultrasound in H-type hypertension

Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study

Hyperhomocysteinemia and Hyperlipidemia in Coronary Heart Disease.

Status of Hyperhomocysteinemia in China: Results from the China Stroke High-risk Population Screening Program, 2018

The correlation between blood pressure and homocysteine in Chinese type Ⅱ diabetes

Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension

Plasma Phospholipid Polyunsaturated Fatty Acids and Homocysteine in Chinese Type 2 Diabetes Patients